GCTK

4.29% -0.0332

Dopo l'orario di chiusura: .73 -0.0099 -1.34%

Glucotrack Inc (GCTK)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Glucotrack Inc Stock (GCTK) Company Profile

Glucotrack Inc

Healthcare (1106)

972 (8) 675-7878

301 RT 17 NORTH, RUTHERFORD

Prossima data di guadagno

Ultimi documenti SEC

GCTK's Discussions on Twitter

Compare GCTK vs ISRG, BDX, MDLN, ALC, RMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GCTK Glucotrack Inc	0.7399	2.83M	0	-19.39M	-15.34M	-18.91
ISRG Intuitive Surgical Inc	431.87	148.77B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	147.51	39.44B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	38.55	33.19B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	63.78	30.25B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	203.79	28.83B	5.54B	1.52B	1.74B	10.37

Glucotrack Inc Borsa (GCTK) Ultime notizie

Glucotrack Inc Azioni (GCTK) Dati Finanziari

Glucotrack Inc (GCTK)

Glucotrack Inc Stock (GCTK) Company Profile

Compare GCTK vs ISRG, BDX, MDLN, ALC, RMD

Glucotrack Inc Borsa (GCTK) Ultime notizie

What you need to know before buying GlucoTrack (GCTK) (+0.76%) 2026-05-08Mid Cap Momentum - newser.com

How GlucoTrack (GCTK) maintains its asset base | GCTK: GlucoTrack Q Results Lack Revenue, EPS DataGuidance Upgrade - newser.com

GCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill

GlucoTrack Files IDE for Implantable Glucose Monitor - TipRanks

IDE filing advances Glucotrack (NASDAQ: GCTK) implantable glucose monitor - Stock Titan

Glucotrack Submits Blood Glucose Monitoring Technology to FDA - Yahoo Finance

Glucotrack Submits IDE to FDA for Implantable Continuous Blood Glucose Monitoring System - geneonline.com

Glucotrack submits FDA application for implantable glucose monitor - Investing.com

Glucotrack submits FDA application for implantable glucose monitor By Investing.com - Investing.com Canada

GlucoTrack, Inc. announced it has officially submitted an Investigational Device Exemption (IDE) application to US regulators for its innovative implantable continuous glucose monitoring technology. - Bitget

Glucotrack, Inc. Submits Investigational Device Exemption Application to FDA for Continuous Blood Glucose Monitoring Technology - Quiver Quantitative

Implantable diabetes monitor moves toward U.S. trial without a wearable - Stock Titan

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology - marketscreener.com

12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm

Glucotrack Announces IDE Submission for U.S. Clinical Study of Its Novel Implantable Continuous Blood Glucose Monitoring Technology - Moomoo

GCTK Stock Jumps As Implantable CGM Data Impresses - StocksToTrade

GCTK Jumps As GlucoTrack’s Implantable CGM Data Impresses - timothysykes.com

Needle-free diabetes care: 6 devices that painlessly monitor blood sugar - Labiotech.eu

see if this zone is the one. $Glucotrack (GCTK.US)$ - Moomoo

GlucoTrack Executes Debt-for-Equity Exchange and Investor Update - The Globe and Mail

GlucoTrack Reports Strong Preclinical Data for Implantable CBGM - The Globe and Mail

Peer-Reviewed Study in Journal of Diabetes Research Verifies Glucotrack’s Long‑Term Continuous Blood Glucose Monitoring Technology - citybiz

[EFFECT] Glucotrack, Inc. SEC Filing - Stock Titan

Glucotrack (NASDAQ: GCTK) swaps $988K debt for 1.3M new shares - Stock Titan

Glucotrack publishes 240-day glucose monitor study results By Investing.com - Investing.com South Africa

Peer-reviewed CBGM data back Glucotrack (NASDAQ: GCTK) IDE plans - Stock Titan

Glucotrack publishes 240-day glucose monitor study results - Investing.com

Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology - The Manila Times

An implantable glucose monitor held accuracy for 240 days in animal study - Stock Titan

Glucotrack, Inc. (NASDAQ: GCTK) registers 20.06M shares tied to $20M financing - Stock Titan

GCTK Stock Chops Higher As GlucoTrack Marks Key CGM Milestones - StocksToTrade

GCTK Stock Pops As GlucoTrack Marks Key CGM Milestones - timothysykes.com

GlucoTrack stock gains as data backs FDA filing plans for glucose monitoring tech - MSN

GCTK stock is soaring pre-market today — what is fueling the surge? - MSN

GlucoTrack Stock Short Interest Falls to 73.9% - Quiver Quantitative

GlucoTrack files to sell 20.06M shares of common stock by selling shareholders - MSN

GCTK GlucoTrack lays out new commercial growth plans in its latest quarterly earnings release for non-invasive glucose monitors.Dividend Report - Cổng thông tin điện tử tỉnh Tây Ninh

Study Supports GlucoTrack’s Blood Glucose Monitoring Implant - Yahoo Finance

GlucoTrack announces publication of peer-reviewed article on glucose sensors - TipRanks

New Peer-Reviewed Study Supports Glucotrack’s Long-Duration Implantable Continuous Blood Glucose Monitoring Technology - citybiz

Glucotrack publishes peer-reviewed study on glucose sensor stability - Investing.com

Glucotrack publishes peer-reviewed study on glucose sensor stability By Investing.com - Investing.com Canada

Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology - marketscreener.com

One-year lab test backs Glucotrack implantable glucose monitor - Stock Titan

GlucoTrack (GCTK) Stock Investment Today (Volatility Increases) 2026-04-20Turnaround Stocks - Cổng thông tin điện tử tỉnh Lào Cai

GCTK | GlucoTrack, Inc. Common Stock Insider Trading - Quiver Quantitative

GlucoTrack (GCTK) Stock Volume Drop (Smart Money Active) 2026-04-18Viral Momentum Stocks - newser.com

Should You Hold GlucoTrack (GCTK) Stock? (Technical Weakness) 2026-04-16Momentum Signals - Xã Vĩnh Công

Glucotrack Inc Azioni (GCTK) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a GCTK